NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAAA E-190-2021-0-US-02 Cannabinoid Receptor Modulating Compounds US National Stage 18/709,949 Pending
NCI E-065-2024-0-US-01 INDUCED NATURAL KILLER CELLS EXPRESSING A MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTOR AND INTERLEUKIN-15 FOR THE TREATMENT OF SOLID TUMORS US 63/647,371 Expired
NCI E-113-2021-0-IN-01 BACTERIOPHAGE LAMBDA-VACCINE SYSTEM IN National Stage 202417037929 Pending
NCI E-198-2018-0-US-02 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF US CON 18/661,979 12492262 Issued PDF
NCI E-142-2014-0-US-02 ANTIGEN-BINDING PROTEINS TARGETING CD56 AND METHODS OF PRODUCING THEREOF US DIV 18/662,315 Pending
NICHD E-200-2021-0-EP-01 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE EP National Stage 22802481.6 Pending
NIAID E-081-2013-4-US-27 PREFUSION RSV F PROTEINS AND THEIR USE US DIV 18/662,792 Abandoned
NEI E-058-2018-0-US-09 Using Machine Learning And/or Neural Networks To Validate Stem Cells And Their Derivatives (2-D Cells And 3-D Tissues) For Use In Cell Therapy And Tissue Engineered Products US CON 18/662,788 Pending
NCI E-129-2023-0-PC-01 SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF PCT PCT PCT/US2024/028832 Expired
NIAID E-135-2025-0-PC-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE PCT PCT COMB PCT/US2024/028751 Expired
NIAID E-171-2021-0-US-02 SARS-COV-2 SPIKE FUSED TO A HEPATITIS B SURFACE ANTIGEN US National Stage 18/709,441 Pending
NIAID E-135-2025-0-US-03 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE US ORD 18/660,581 Pending
NCI E-205-2021-0-US-02 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF US National Stage 18/708,747 Pending
NIAID E-531-2013-2-US-17 EPSTEIN-BARR VIRUS VACCINES US DIV 18/659,639 Pending
NCI E-033-2024-0-US-01 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS US 63/644,728 Expired
NCI E-237-2017-2-MX-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 MX DIV MX/a/2024/005678 Pending
NCI E-237-2017-2-MX-03 T CELL RECEPTORS RECOGNIZING MUTATED P53 MX DIV MX/a/2024/005676 Pending
NCI E-237-2017-2-MX-02 T CELL RECEPTORS RECOGNIZING MUTATED P53 MX DIV MX/a/2024/005677 Pending
NIAID E-081-2013-4-EP-25 Prefusion RSV F Proteins And Their Use EP DIV 24174501.7 Pending
NCI E-205-2021-0-JP-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF JP National Stage 2024-526841 Pending
NIAID E-095-2021-0-US-02 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US National Stage 18/707,305 Pending
NIAID E-160-2021-0-EP-01 AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 EP National Stage 22803142.3 Pending
NIBIB E-168-2021-2-US-01 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL STRUCTURED ILLUMINATION
MICROSCOPY WITH ISOTROPIC SPATIAL RESOLUTION IMPROVEMENT OF AXIAL RESOLUTION IN 3D SIM VIA OPTICAL AND COMPUTATIONAL MEANS 		US National Stage 18/707,466 Abandoned
NEI E-126-2024-0-US-01 CORYNEBACTERIUM MASTITIDIS-DERIVED MYCOLATES FOR TREATING OCULAR SURFACE DISEASES US 63/642,512 Expired
NLM E-107-2010-2-US-41 METHODS OF EPIGENETIC ANALYSIS US CON 18/654,759 Abandoned
NCI E-042-2014-0-JP-01 Chimeric Antigen Receptors Targeting CD-19 JP DIV 2024-074954 Issued
NIEHS E-164-2023-0-PC-01 APOE-ACTIVATING NONCODING RNA (ERNA) AND USES THEREOF PCT PCT PCT/US2024/027272 Expired
NCI E-169-2021-0-CN-01 MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE CN National Stage 202280073643.1 Pending
NCI E-138-2024-0-US-01 Methods of Determining Likelihood of Response to Anti-PD-L1 Antibodies in Lung Cancer Patients US 63/640,731 Abandoned
NIAID E-041-2024-0-US-01 ANTIBODIES AGAINST EV-D68 US 63/640,619 Expired
NCATS E-095-2025-0-US-01 Synthetic Superstolides and Therapeutic Use Thereof US 63/640,720 Expired
NICHD E-200-2021-0-US-02 USE OF CARBOXYPEPTIDASE E/NEUROTROPHIC FACTOR-ALPHA1 TO TREAT NEURODEGENERATIVE DISEASE US National Stage 18/705,869 Pending
NIAID E-066-2014-0-US-28 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US DIV 18/648,190 12268737 Issued PDF
NCI E-125-2021-0-US-03 METHODS AND MATERIALS FOR LARGE-SCALE ASSESSMENT OF LIGAND BINDING SELECTIVITY OF G-QUADRUPLEX RECOGNITION USING CUSTOM G4 MICROARRAYS US CON 18/648,173 Pending
NCI E-209-2014-0-JP-01 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV 2024-073035 Pending
NIBIB E-168-2021-2-CN-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy With Isotropic Spatial Resolution CN National Stage 202280072069.8 Abandoned
NCI E-282-2016-2-IL-03 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY IL DIV 312426 Pending
NCI E-204-2021-0-US-02 SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN US National Stage 18/704,211 Pending
NCI E-017-2017-0-US-11 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US CON 18/644,724 Pending
OD E-120-2021-0-US-02 PREDICTION OF TRANSFORMATIVE BREAKTHROUGHS IN RESEARCH US National Stage 18/703,175 12536216 Issued PDF
NIDCR E-130-2023-0-PC-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS PCT PCT PCT/US2024/025390 Expired
NCI E-068-2018-0-CN-01 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 CN DIV 202410477974.2 Pending
NIDCR E-130-2023-0-TW-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS TW ORD 113114733 Pending
NIA E-030-2024-0-US-01 Acceleration of multidimensional MRI acquisition via k-space subsampling and partial reconstruction US 63/635,694 Expired
NIAID E-234-2016-1-US-05 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US CON 18/638,334 Abandoned
NCI E-020-2024-0-US-01 Chimeric Antigen Receptors targeting FGFR4 and/or CD276 with CD28 HTM and CSD for childhood rhabdomyosarcoma US 63/634,330 Expired
NCI E-181-2017-0-MX-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS MX DIV MX/a/2024/004610 Pending
NCATS E-172-2021-0-KR-01 SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES KR National Stage 10-2024-7012300 Abandoned
NCI E-155-2024-0-US-01 MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF US 63/633,193 Expired
NCI E-003-2022-0-US-02 AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING US National Stage 18/700,977 Pending